Terminated PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01596829

Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea

Sponsor: Danisco

Conditions Antibiotic-associated Diarrhoea

Updated 5 times since 2017 Last updated: Jan 21, 2016 Started: Dec 31, 2012 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

low incidence

Other terminated trials from Danisco

See all terminations from Danisco

A PHASE2/PHASE3 clinical study on Antibiotic-associated Diarrhoea, this trial is terminated or withdrawn. The trial is conducted by Danisco and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2_PHASE3

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Danisco

Data source: Danisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tampere, Finland